Search

Champions Oncology Inc

Geschlossen

BrancheGesundheitswesen

4.83 0.84

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

4.79

Max

4.83

Schlüsselkennzahlen

By Trading Economics

Einkommen

241K

-426K

Verkäufe

1.4M

15M

KGV

Branchendurchschnitt

35.118

47.946

EPS

-0.03

Gewinnspanne

-2.797

Angestellte

214

EBITDA

79K

-95K

Dividenden

By Acuity

Nächstes Ergebnis

14. Dez. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-3.3M

69M

Vorheriger Eröffnungskurs

3.99

Vorheriger Schlusskurs

4.83

Champions Oncology Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

7. Okt. 2026, 20:07 UTC

Champions Oncology Inc's shares are declining sharply, reversing earlier gains and reflecting broader market trends with notable volatility.

6. Okt. 2026, 20:06 UTC

Champions Oncology Inc shares are rising amid a higher market, as U.S. trade data showed a widening deficit of $105.6 billion and improving consumer sentiment.

2. Okt. 2026, 20:00 UTC

Champions Oncology Inc is advancing, having gained ground since Thursday's close, despite pulling back from a session high earlier in the day.

30. Sept. 2026, 19:52 UTC

Champions Oncology Inc is gaining significantly on Wednesday, peaking around mid-day despite trading below its 20-day moving average.

29. Sept. 2026, 19:36 UTC

Champions Oncology Inc. shares fell sharply after mid-morning volatility, remaining below the 20-day moving average and near the lower end of its one-month range.

22. Sept. 2026, 20:06 UTC

Champions Oncology Inc shares fell slightly, finishing lower compared to Monday's close, despite an early drop and subsequent recovery within a typical daily range.

21. Sept. 2026, 19:16 UTC

Champions Oncology Inc shares fell sharply, continuing a downward trend from Friday's close, reaching their lowest point of the day.

18. Sept. 2026, 20:02 UTC

Champions Oncology Inc shares fell slightly, continuing a downward trend since Thursday, despite an early recovery during Friday's trading session.

17. Sept. 2026, 20:01 UTC

News

Champions Oncology reported record annual revenue of $59.4 million for fiscal 2026, with shares trading higher amid a positive adjusted EBITDA of $1.6 million.

16. Sept. 2026, 19:06 UTC

Champions Oncology Inc is trading higher, experiencing significant volatility with a sharp midday rise after an initial dip, contrasting with three prior sessions that closed lower.

15. Sept. 2026, 20:03 UTC

News

Champions Oncology reports a net loss of $426,000 and revenue of $15.2 million. Shares are lower amid broader market declines following weak manufacturing data.

11. Sept. 2026, 19:56 UTC

News

Champions Oncology reported Q1 fiscal 2027 revenue of $15.2 million. Shares are lower despite improved gross margin and adjusted EBITDA of approximately $700,000.

10. Sept. 2026, 20:01 UTC

Champions Oncology Inc shares are higher today, continuing upward momentum after three consecutive sessions of decline. The stock remains above its 20-day moving average.

9. Sept. 2026, 20:07 UTC

Champions Oncology Inc shares declined for a fourth straight day, reaching a session low earlier. No specific news was identified to explain the movement.

8. Sept. 2026, 20:13 UTC

Champions Oncology Inc shares are lower in after-market hours, continuing a trend of declining performance over the past three sessions.

4. Sept. 2026, 19:07 UTC

Champions Oncology Inc is trading lower after reversing early gains, reflecting a decline since Thursday's close amid unchanged unemployment rates and decelerating wage growth.

3. Sept. 2026, 20:01 UTC

Champions Oncology Inc shares are higher today, maintaining strong upward momentum since Wednesday's close, despite no specific news to explain the movement.

2. Sept. 2026, 20:08 UTC

Champions Oncology Inc shares are higher today, breaking from a recent pattern of daily gains. No specific news was identified to explain the movement.

28. Aug. 2026, 19:36 UTC

Champions Oncology Inc. shares are trading roughly flat, with no specific news identified. The stock remains near the lower end of its one-month range.

27. Aug. 2026, 20:03 UTC

Champions Oncology shares are higher Thursday, reflecting a broader market trend amid declining initial jobless claims reported by the Labor Department.

25. Aug. 2026, 19:16 UTC

Champions Oncology Inc. is trading higher today, despite a flat performance and remaining below its 20-day moving average. No specific news was identified.

24. Aug. 2026, 20:06 UTC

News

Champions Oncology reports gross revenue of $59.42 million, with shares declining since Friday's close despite an earlier session increase.

21. Aug. 2026, 20:06 UTC

Champions Oncology Inc shares are lower in Friday's session amid broader market declines, with no specific news identified to explain the volatility.

20. Aug. 2026, 19:31 UTC

Champions Oncology Inc is higher today, driven by gains in the Life Sciences Tools & Services sub-sector, despite earlier session declines.

19. Aug. 2026, 20:02 UTC

Champions Oncology Inc shares declined during Wednesday's session, reaching a low in late morning amid no specific news to explain the downturn.

18. Aug. 2026, 19:41 UTC

Champions Oncology Inc shares are higher today, despite no specific news. Broader market concerns include inflation and rising treasury yields affecting investor sentiment.

17. Aug. 2026, 19:36 UTC

Champions Oncology Inc's shares are higher during Monday's session, reflecting a modest increase since Friday's close. The stock remains below its 20-day moving average.

14. Aug. 2026, 20:02 UTC

Champions Oncology is trading lower, reflecting broader market sentiment amid a surprising decline in U.S. retail sales for July.

13. Aug. 2026, 19:26 UTC

Champions Oncology Inc shares are higher during Thursday's session, rebounding from an earlier dip despite remaining below the 20-day moving average.

12. Aug. 2026, 19:51 UTC

Champions Oncology Inc's shares are lower today, diverging from recent gains, with no specific news identified to explain the decline.

Peer-Vergleich

Kursveränderung

Champions Oncology Inc Prognose

Rating-Konsens

By TipRanks

0 ratings

0

Buy

0

Halten

0

Sell

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.